Ross C. Donehower

36.5k citations
223 papers · 16.0k indexed · 5 hit papers · h-index 66

Impact in

  • Oncology top 0.05%
    • Cancer Treatment and Pharmacology
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Cancer Treatment and Pharmacology 69
    • Colorectal Cancer Treatments and Studies 41
    • Pancreatic and Hepatic Oncology Research 31
    • Lung Cancer Research Studies 18
    • Neutropenia and Cancer Infections 17
    • Cancer Genomics and Diagnostics 17

Ross C. Donehower

218 papers receiving 15.5k citations

Hit Papers

PD-1 blockade in tumors with mismatch repair deficiency. 2015 · 339 citations
339199020262002201450010001.5k

Peers

Ross C. Donehower
Comparison fields: 5 of 148
  • Oncology 10.1k
  • Cancer Research 1.6k
  • Dermatology 847
  • Hepatology 733
  • Hematology 949
Replace Patricia LoRusso with:
Patricia LoRusso United States
Sandrine Faivre France
Chris Twelves United Kingdom
Eric K. Rowinsky United States
Merrill J. Egorin United States
Mace L. Rothenberg United States
Stan B. Kaye United Kingdom
Geoffrey R. Weiss United States
Bernd Dörken Germany
Tito Fojo United States
Ross C. Donehower relative to Patricia LoRusso United States Patricia LoRusso's profile →
Citations per field
00.5×1.5×
Patricia LoRusso · 1×
Citations per year

Countries citing papers authored by Ross C. Donehower

Since Specialization
Citations

This map shows the geographic impact of Ross C. Donehower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross C. Donehower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross C. Donehower more than expected).

Fields of papers citing papers by Ross C. Donehower

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross C. Donehower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross C. Donehower. The network helps show where Ross C. Donehower may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ross C. Donehower, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ross C. Donehower Line = papers co-authored together Ross C. Donehower links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201968
2 201328
3 201316
4 201215
5 201129
6 201062
7 20063
8 20036
9 199817
10 1996151
11 199641
12 199533
13 199448
14 1993157
15 19904
16 199011
17
Taxol: A Novel Investigational Antimicrotubule Agent
Hit paper breakdown →
1990895
18 19891
19
Microtubule changes and cytotoxicity produced by taxol in human ovarian cell lines
19871
20
Reversibility of high-affinity binding of methotrexate in L1210 murine leukemia cells.
197825

About Ross C. Donehower

Ross C. Donehower is a scholar working on Oncology, Cancer Research, Hematology, Pulmonary and Respiratory Medicine and Dermatology, having authored 223 papers that have together received 16.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (69 papers), Cancer therapeutics and mechanisms (44 papers), Colorectal Cancer Treatments and Studies (41 papers), Pancreatic and Hepatic Oncology Research (31 papers), Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (18 papers), Cancer Genomics and Diagnostics (17 papers) and Neutropenia and Cancer Infections (17 papers). The work is most often cited by research in Oncology (10.1k citations), Cancer Research (1.6k citations), Dermatology (847 citations), Hepatology (733 citations) and Hematology (949 citations). Ross C. Donehower has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Eric K. Rowinsky, Lorraine A. Cazenave, L B Grochow, Scott H. Kaufmann, S E Sartorius, Daniel A. Laheru, Louise B. Grochow, Sharyn D. Baker, William J. Slichenmyer and Vinay Chaudhry. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, JNCI Journal of the National Cancer Institute, Investigational New Drugs and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026